3.02
price up icon3.78%   0.11
pre-market  Vorhandelsmarkt:  3.26   0.24   +7.95%
loading
Schlusskurs vom Vortag:
$2.91
Offen:
$2.92
24-Stunden-Volumen:
225.72K
Relative Volume:
0.09
Marktkapitalisierung:
$4.02M
Einnahmen:
$9.81M
Nettoeinkommen (Verlust:
$-26.16M
KGV:
-0.0779
EPS:
-38.77
Netto-Cashflow:
$-17.45M
1W Leistung:
+12.69%
1M Leistung:
+18.43%
6M Leistung:
-97.20%
1J Leistung:
-98.99%
1-Tages-Spanne:
Value
$2.85
$3.10
1-Wochen-Bereich:
Value
$2.5709
$3.22
52-Wochen-Spanne:
Value
$2.23
$323.35

Reshape Lifesciences Inc Stock (RSLS) Company Profile

Name
Firmenname
Reshape Lifesciences Inc
Name
Telefon
949-429-6680
Name
Adresse
1001 CALLE AMANECER, SAN CLEMENTE
Name
Mitarbeiter
18
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
RSLS's Discussions on Twitter

Vergleichen Sie RSLS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
RSLS
Reshape Lifesciences Inc
3.02 6.39M 9.81M -26.16M -17.45M -38.77
Medical Devices icon
ABT
Abbott Laboratories
125.73 228.77B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
103.16 153.09B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
395.15 149.27B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
91.65 114.31B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
76.30 45.06B 5.54B 4.18B 623.10M 7.00

Reshape Lifesciences Inc Aktie (RSLS) Neueste Nachrichten

pulisher
02:19 AM

Is ReShape Lifesciences Inc. a good long term investmentOutstanding growth strategies - Autocar Professional

02:19 AM
pulisher
Jul 22, 2025

What analysts say about ReShape Lifesciences Inc. stockExceptional risk-adjusted gains - printweek.in

Jul 22, 2025
pulisher
Jul 22, 2025

ReShape's New Lap-Band 2.0 FLEX Targets GLP-1 Era: Top Surgeons Gather for Groundbreaking Summit - Stock Titan

Jul 22, 2025
pulisher
Jul 22, 2025

ReShape Lifesciences® to Host Inaugural Lap-Band® Surgeon Summit - GlobeNewswire

Jul 22, 2025
pulisher
Jul 21, 2025

ReShape Lifesciences Hosts Special Meeting of Stockholders on July 24, 2025 - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

ReShape Lifesciences Board Unanimously Recommends Merger with Vyome Therapeutics and Sale of Assets to Biorad Medisys - Nasdaq

Jul 21, 2025
pulisher
Jul 21, 2025

ReShape Lifesciences® Receives Notice of Allowance for Key U.S. Patent Related to an Intragastric Balloon System - Yahoo.co

Jul 21, 2025
pulisher
Jul 21, 2025

ReShape Lifesciences® to Host Special Meeting of Stockholders on July 24, 2025 - GlobeNewswire

Jul 21, 2025
pulisher
Jul 21, 2025

ReShape Lifesciences® to Host Special Meeting of Stockholders on July 24, 2025 - Benzinga

Jul 21, 2025
pulisher
Jul 21, 2025

ReShape Lifesciences Strategic Transformation: Board and Proxy Advisors Unite Behind Vyome Merger - Stock Titan

Jul 21, 2025
pulisher
Jul 20, 2025

ReShape Lifesciences Inc. Stock Analysis and ForecastRapid portfolio appreciation - Autocar Professional

Jul 20, 2025
pulisher
Jul 19, 2025

What drives ReShape Lifesciences Inc. stock priceUnmatched profit growth - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 18, 2025

How high can ReShape Lifesciences Inc. stock price go in 2025Free Access to Community - Newser

Jul 18, 2025
pulisher
Jul 16, 2025

ReShape Lifesciences Announces Merger with Vyome Therapeutics - The Globe and Mail

Jul 16, 2025
pulisher
Jul 16, 2025

Why ReShape Lifesciences Inc. stock attracts strong analyst attentionFree Stock Selection with 300% Return - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

What makes ReShape Lifesciences Inc. stock price move sharplyFree Join Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How ReShape Lifesciences Inc. stock performs during market volatilityFree Capital Growth Strategies - Newser

Jul 15, 2025
pulisher
Jul 03, 2025

ReShape Lifesciences Loans $200K to Vyome Therapeutics - TipRanks

Jul 03, 2025
pulisher
Jul 01, 2025

ReShape Lifesciences to receive patent for swallowable balloon device - Investing.com

Jul 01, 2025
pulisher
Jul 01, 2025

ReShape Lifesciences® Granted U.S. Patent Related to an Intragastric Balloon System - The Manila Times

Jul 01, 2025
pulisher
Jul 01, 2025

Game-Changing Patent: ReShape's New Self-Degrading Weight Loss Balloon Could Transform Obesity Treatment - Stock Titan

Jul 01, 2025
pulisher
Jun 29, 2025

RSLS 425及美國證券交易委員會申報文件 - Yahoo 財經

Jun 29, 2025
pulisher
Jun 28, 2025

ReShape Lifesciences: Navigating Regulatory Recovery – Is This Turnaround Sustainable? - AInvest

Jun 28, 2025
pulisher
Jun 27, 2025

ReShape Lifesciences regains Nasdaq compliance after equity raises By Investing.com - Investing.com South Africa

Jun 27, 2025
pulisher
Jun 27, 2025

ReShape Lifesciences regains Nasdaq compliance after equity raises - Investing.com India

Jun 27, 2025
pulisher
Jun 26, 2025

ReShape Lifesciences cuts workforce to save $750k annually - Investing.com

Jun 26, 2025
pulisher
Jun 26, 2025

About Us - FinancialContent

Jun 26, 2025
pulisher
Jun 19, 2025

ReShape Lifesciences boosts stockholders’ equity above Nasdaq minimum By Investing.com - Investing.com India

Jun 19, 2025
pulisher
Jun 18, 2025

ReShape Lifesciences boosts stockholders’ equity above Nasdaq minimum - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

ReShape Lifesciences Raises Equity to Avoid Delisting - TipRanks

Jun 18, 2025
pulisher
Jun 16, 2025

ReShape Lifesciences Stock Soars On Distribution Agreement With Recon Supply, Draws Retail Applause - MSN

Jun 16, 2025
pulisher
Jun 13, 2025

Reshape Lifesciences Stock Price, Quotes and Forecasts | NASDAQ:RSLS - Benzinga

Jun 13, 2025
pulisher
Jun 13, 2025

Why Did ReShape Lifesciences Plunge 12.54%? Public Offering Concerns - AInvest

Jun 13, 2025
pulisher
Jun 12, 2025

ReShape Lifesciences Closes $2.6M Stock Offering - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

ReShape Lifesciences signs distribution deal with Recon Supply By Investing.com - Investing.com Canada

Jun 12, 2025
pulisher
Jun 12, 2025

ReShape Lifesciences (RSLS) Stock Skyrockets Over 30% in Highly Volatile Session - Daily Chhattisgarh News

Jun 12, 2025

Finanzdaten der Reshape Lifesciences Inc-Aktie (RSLS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$285.57
price up icon 1.64%
medical_devices STE
$223.69
price up icon 0.47%
medical_devices PHG
$25.02
price up icon 1.96%
$85.12
price up icon 1.30%
$76.49
price up icon 3.14%
medical_devices EW
$76.30
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):